get a key
steadybase-$ company CDXS
account_id none on file
legal_name Codexis, Inc.
ticker CDXS
cik 1200375
domain codexis.com
entry_point_account_id none on file
name Codexis Inc.
exchange Nasdaq
sector Industrials
hq Redwood City, CA, United States
calls 2 filings 60 executives 5 family 0
why_nownone on file
calls
Including our anticipated build-out of the Ecosynthesis Innovation Lab, we continue to expect that our existing cash and cash equivalents, combined with our future expectations for product revenues, R&D revenues, and expense management, will be sufficient to fund our planned operations and cash flow grant even around the end of 2026.

Feb 28, 2024 / receipt, needs a key / Sri, CFO | earnings call 2024-02-28 | transcript 35a44d7e-3e5a-4d76-929c-4732244180af | chars 27553-27888 | segment 27

We expect that our existing cash and cash equivalents, combined with our future expectations for product revenues, R&D revenues, and expense management, will be sufficient to fund our planned operations through the end of 2024.

Aug 4, 2022 / receipt, needs a key / Ross, CFO | earnings call 2022-08-04 | transcript 8d005b30-2f6f-4b97-879d-2aac8b766292 | chars 26410-26637 | segment 26

filings
Reduces costs and improves purity and yield

ir_statement / Sep 16, 2026 / receipt

$10B to $20B infrastructure investment required to meet anticipated annual demand of ~30K kg by ~2030

ir_statement / Sep 15, 2026 / receipt

Agilent invested $725M in facility expansion1 to produce up to 1K kg of RNAi per year

ir_statement / Sep 15, 2026 / receipt

Reduces costs and improves purity and yield

ir_statement / Sep 15, 2026 / receipt

$10B to $20B infrastructure investment required to meet anticipated annual demand of ~30K kg by ~2030

ir_statement / Sep 15, 2026 / receipt

Agilent invested $725M in facility expansion1 to produce up to 1K kg of RNAi per year

ir_statement / Sep 15, 2026 / receipt

Reduces costs and improves purity and yield

ir_statement / Sep 15, 2026 / receipt

Reduces costs and improves purity and yield

ir_statement / Sep 15, 2026 / receipt

Eliminating 46 positions, which is expected to reduce operating expenses by 25%

ir_statement / Sep 15, 2026 / receipt

Reducing operating expenses

ir_statement / Sep 15, 2026 / receipt

Achieving Operational Efficiency

ir_statement / Sep 15, 2026 / receipt

Reduction in expenses across all areas of the organization

ir_statement / Sep 15, 2026 / receipt

executives
Byron L. Dorgan director - receipt
Gordon Sangster Chief Financial Officer, Senior Vice President linkedin receipt
John Nichols CEO - receipt
Stephen Dilley CEO - receipt
Stephen Dilly President and Chief Executive Officer - receipt
familynone on file
upcoming
2026-11-05 earnings call scheduled ir
changes
2022-07-18 President and Chief Executive Officer, appointed sec_8k
2014-07-28 Senior Vice President and Chief Financial Officer, appointed sec_8k
2014-06-30 Senior Vice President and Chief Financial Officer, departed sec_8k
2012-09-04 Senior Vice President and Chief Financial Officer, appointed sec_8k
2012-06-21 Senior Vice President and Chief Business Officer, departed sec_8k
2012-03-09 Senior Vice President and Chief Financial Officer, departed sec_8k
2012-02-21 director, departed sec_8k
2011-02-24 director, appointed sec_8k
mcp_package_hint
steadybase-$